Table II.

Pediatric CCCG-BNHL-2015 regimen.

	Dose	Administration	Days
AA (R4 + rituximab)
Cyclophosphamide	800 mg/m2	IV over 2 h	D1
Cyclophosphamide	200 mg/m2	IV over 1 h	D2, 3, 4
Vindesine	3 mg/m2 (max 5 mg)	IV	D1
Doxorubicin	20 mg/m2	IV over 2 h	D2, D3
Cytarabine	2,000 mg/m2	IV over 3 h	D4 (q12 h)
Prednisone	60 mg/m2	Per os	D1-7
Triple sheath note (dose by age)			D1, D8
BB (R4 + rituximab)
Ifosfamide	1,200 mg/m2	IV over 2 h	D1-5
	Mesna 400 mg/m2,
	0, +4, +8 h
Etoposide	100 mg/m2	IV over 2 h	D3-5
Methotrexate	5,000 mg/m2	IV over 24 h	D1
Vindesine	3 mg/m2 (max 5 mg)	IV	D1
Prednisone	60 mg/m2	Per os	D1-7
Triple sheath note (dose by age)			D1, D8